Daisuke Nakano Selected Research

Desmin

1/2019	Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
11/2010	Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daisuke Nakano Research Topics

Disease

30	Hypertension (High Blood Pressure) 01/2022 - 09/2002
20	Neoplasms (Cancer) 11/2023 - 05/2010
16	Insulin Resistance 01/2023 - 09/2009
14	Fibrosis (Cirrhosis) 09/2022 - 09/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2008
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2010
9	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2008
9	Hypoxia (Hypoxemia) 06/2021 - 10/2005
9	Albuminuria 01/2020 - 11/2010
8	Obesity 11/2021 - 12/2012
7	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2009
7	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2023 - 07/2011
7	Glucose Intolerance 01/2022 - 01/2010
7	Inflammation (Inflammations) 11/2021 - 05/2010
6	Body Weight (Weight, Body) 01/2022 - 07/2010
6	Hyperglycemia 01/2022 - 07/2016
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 11/2008
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2011
5	Chronic Renal Insufficiency 06/2021 - 09/2017
5	Anemia 06/2021 - 09/2017
5	Proteinuria 03/2020 - 09/2009
4	Rectal Neoplasms (Rectal Cancer) 04/2024 - 11/2008
4	Hemorrhage 04/2022 - 01/2018
3	Non-alcoholic Fatty Liver Disease 09/2022 - 01/2022
3	Fistula 04/2022 - 11/2008
3	Wounds and Injuries (Trauma) 01/2022 - 09/2009
3	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2012
3	Ischemia 01/2021 - 04/2014
3	Reperfusion Injury 01/2021 - 04/2014
3	Glycosuria 07/2020 - 06/2018
3	Vascular Remodeling 01/2014 - 10/2011
3	Hypertrophy 02/2012 - 04/2011
3	Carcinoma (Carcinomatosis) 05/2010 - 11/2008
2	Colonic Neoplasms (Colon Cancer) 11/2023 - 07/2018
2	Fatty Liver 01/2022 - 12/2012
2	Dehydration (Water Stress) 11/2021 - 12/2020
2	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 01/2017
2	Kidney Diseases (Kidney Disease) 12/2020 - 07/2016
2	Adenocarcinoma 01/2020 - 03/2015

Drug/Important Bio-Agent (IBA)

20	SaltsIBA 01/2022 - 12/2003
19	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
13	Angiotensin IIIBA 01/2022 - 09/2009
10	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2022 - 04/2012
10	Messenger RNA (mRNA)IBA 11/2021 - 09/2009
9	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 05/2016
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2009
9	Insulin (Novolin)FDA Link 01/2022 - 02/2011
9	olmesartanIBA 01/2018 - 12/2007
8	AldosteroneIBA 01/2022 - 09/2009
8	SodiumIBA 01/2022 - 01/2013
8	ReninIBA 01/2020 - 09/2009
7	Angiotensin Receptor AntagonistsIBA 01/2022 - 06/2006
5	Erythropoietin FDA Link 12/2020 - 02/2016
5	Eplerenone (Inspra)FDA LinkGeneric 03/2012 - 09/2009
4	CreatinineIBA 01/2023 - 01/2018
4	AntioxidantsIBA 09/2022 - 10/2011
4	Sulfides (Thioethers)IBA 09/2021 - 01/2012
4	Adenine FDA LinkGeneric 12/2020 - 09/2017
4	Hydralazine (Apresoline)FDA LinkGeneric 03/2020 - 12/2003
4	Prorenin ReceptorIBA 01/2020 - 01/2010
4	Desoxycorticosterone Acetate (DOCA)FDA Link 03/2008 - 12/2003
3	WithanolidesIBA 09/2023 - 07/2011
3	Oxidants (Oxidizing Agents)IBA 09/2022 - 01/2018
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 11/2013
3	Urea (Carbamide)FDA LinkGeneric 01/2022 - 07/2020
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
3	LignansIBA 12/2021 - 09/2002
3	Blood Glucose (Blood Sugar)IBA 11/2021 - 02/2011
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 06/2021 - 02/2016
3	esaxerenoneIBA 02/2021 - 01/2019
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 07/2020 - 04/2017
3	CateninsIBA 01/2020 - 03/2015
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 02/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018 - 04/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 06/2006
3	FructoseIBA 11/2013 - 09/2009
3	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2013 - 12/2006
3	sesaminIBA 03/2008 - 09/2002
2	Indicators and Reagents (Reagents)IBA 04/2024 - 12/2021
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2010
2	Drinking WaterIBA 01/2022 - 09/2009
2	LipidsIBA 01/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 06/2009
2	molidustatIBA 06/2021 - 12/2020
2	NitrogenIBA 12/2020 - 07/2020
2	Valsartan (Vals)FDA Link 03/2020 - 01/2012

Therapy/Procedure

15	Therapeutics 01/2023 - 12/2003
9	Drug Therapy (Chemotherapy) 12/2012 - 11/2008
6	Gastrectomy 12/2020 - 11/2010
4	Neoadjuvant Therapy 04/2024 - 06/2009
4	Oral Administration 06/2018 - 04/2007
3	Caloric Restriction 01/2023 - 01/2020
2	Chemoradiotherapy 04/2024 - 11/2009
2	Colectomy 11/2023 - 12/2020
2	Surgical Instruments (Clip) 04/2022 - 02/2022
2	Nephrectomy 06/2021 - 01/2021
2	Denervation 01/2020 - 03/2012
2	Resuscitation 01/2020 - 12/2015